Obatala Sciences Inc

Obatala Sciences, Inc (www.obatalasciences.com) is a biotechnology toolkit firm that is addressing a critically unmet knowledge gap within the fields of obesity, diabetes, and regenerative medicine. This knowledge gap contributes to a $2 Trillion global economic burden annually and makes a tremendous impact on the development of safe and effective therapies. There’s a need for more diverse human tissue models that aren’t as heavily reliant on small animals and animal-derived research tools. Our team consists of thought leaders and serial entrepreneurs with 70+ years of experience in human biology and regenerative medicine, so we are well-positioned to address this gap, by providing first to market human-derived hydrogels and supportive products to mimic human tissue. We offer these as products and services, and we are ready to help our customers understand the impact of obesity and other co-morbidities on COVID-19 mortality rates. More specifically, we manufacture adult stem cells, cell culture media, and human-derived gels for mimicking human tissue.